Arteriovenous malformation Map2k1 mutation affects vasculogenesis

Area of Science:

• Vascular Biology
• Genetics
• Developmental Biology

Background:

• Somatic activating mutations in MAP2K1 are implicated in endothelial cell (EC) dysfunction leading to extracranial arteriovenous malformations (AVMs).
• Previous work established a mouse model (R26^{GT-Map2k1-GFP/+}) with inducible expression of constitutively active MAP2K1 (p.K57N) in ECs, demonstrating its sufficiency in causing vascular malformations.

Purpose of the Study:

• To elucidate the molecular mechanisms by which mutant MAP2K1 drives AVM development.
• To identify key genes and pathways affected by MAP2K1 overexpression in ECs during early postnatal development.

Main Methods:

• Inducible expression of mutant MAP2K1 (p.K57N) in ECs of postnatal day-1 mouse pups.
• RNA sequencing (RNA-seq) analysis of brain ECs from mutant and wild-type littermates at postnatal day 9.
• Immunostaining to validate differential gene expression, specifically for COL15A1.

Main Results:

• Overexpression of mutant MAP2K1 in ECs altered the transcript abundance of over 1600 genes.
• Significant fold-changes were observed in genes such as Col15a1 (39-fold) and Itgb3 (24-fold).
• Gene ontology analysis revealed enrichment in pathways critical for vasculogenesis, including cell migration, adhesion, extracellular matrix organization, tube formation, and angiogenesis.

Conclusions:

• Mutant MAP2K1 expression profoundly impacts the EC transcriptome, driving changes in genes essential for vascular development.
• The identified differentially expressed genes and pathways offer potential therapeutic targets for AVMs.
• Further investigation into these specific genes and pathways will enhance understanding of AVM pathogenesis.